Sairiv Pharmaceuticals Private Limited, a active private limited company, was established on 06 December 2017 in Chennai, Tamil Nadu, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U74999TN2017PTC119856. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Formerly known as Sunriv Kare Life Private Limited, Sunriv Pharmaceuticals Private Limited. It upholds a compliant status. Its leadership includes Srinivasan Venugopal Rangarajaan (Director), Elangovan Balamurugan (Director). Past directors included Ammanur Gomatam Manivannan, Thangaraj Suyaraj, Veeraraghavan Subharangarajan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No. 120, Shop No 6, Ramachandra Complex Rajas Garden Main Road, Vanagaram, Porur, Chennai, Tamil Nadu, 600095.
U74999TN2017PTC119856
119856
06 December 2017
₹0.10 M
₹0.10 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sairiv Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srinivasan Venugopal Rangarajaan | Director | 06 Dec 2017 | Current |
| Elangovan Balamurugan | Director | 21 Jan 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
| Pramod Abcsdd | Director | 31 Mar 2023 | Past |
| Pramod Abcsdd | Director | 04 Feb 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sairiv Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.75% increase. The company also saw a substantial improvement in profitability, with a 69.09% increase in profit. The company's net worth Soared by an impressive increase of 199.46%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sairiv Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sairiv Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sairiv Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sairiv Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Elangovan Balamurugan was appointed as a Director was appointed as a Director on 21 Jan 2025 & has been associated with this company since 11 months 5 days . was documented.
Progress on Sairiv Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sairiv Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on Srinivasan Venugopal Rangarajaan was appointed as a Director was appointed as a Director on 06 Dec 2017 & has been associated with this company since 8 years 20 days . was documented.
Progress on Sairiv Pharmaceuticals Private Limited was registered on 06 Dec 2017 with Roc Chennai & aged 8 years 20 days as per MCA records. was documented.
The CIN of Sairiv Pharmaceuticals Private Limited is U74999TN2017PTC119856.
Sairiv Pharmaceuticals Private Limited is headquartered at No. 120, Shop No 6, Ramachandra Complex Rajas Garden Main Road, Vanagaram, Porur, Chennai, Tamil Nadu, 600095.
Sairiv Pharmaceuticals Private Limited was incorporated on 06 December 2017.
The current directors of Sairiv Pharmaceuticals Private Limited are
The primary industry of Sairiv Pharmaceuticals Private Limited is Trade.
Sairiv Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sairiv Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Sairiv Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX